TearSolutions: Naturally Treating Dry Eye (225)

Episode 25 • July 04, 2022 • 00:23:20
TearSolutions: Naturally Treating Dry Eye (225)
Innovation4Alpha
TearSolutions: Naturally Treating Dry Eye (225)

Jul 04 2022 | 00:23:20

/

Show Notes

TearSolutions' lead product, called Lacripep, delivers what no other approved or pipeline drug has been able to: rapid healing of the ocular surface and relief of dry eye symptoms with a best-in-class safety and comfort profile. This was all proven in their first-in-human clinical trial which has led to formal written FDA alignment on our clinical and regulatory path to an unrestricted general Dry Eye indication (which is the same path a dry eye drug called Xiidra took, which sold to Novartis for $5.3B). 

The company is raising capital to get Lacripep back into the clinic for the first of two Phase III trials.

Other Episodes

Episode 27

November 26, 2021 • 00:27:25
Episode Cover

Matan Magril - Innovator, Investor and Guide (027)

One of the most creative, insightful and articulate startup leaders in the industry, Matan Magril is always fascinating to talk with. At 22, he...

Listen

Episode 16

August 04, 2021 • 00:35:31
Episode Cover

Featured Family Office: Nottingham Spirk / Katherine Hill Ritchie (016)

Katherine Hill Ritchie has extensive background running single family offices including a strong emphasis on sourcing alternative investments. Her most recent role involves both...

Listen

Episode 12

July 21, 2021 • 00:44:33
Episode Cover

Clinician Innovator and Investor: Jeremy Krell, DMD (012)

Dr. Krell is a fascinating general dentist with a combined business background. He is currently the Head of Marketing at Simplifeye, based in NYC,...

Listen